​

Bausch + Lomb (BLCO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BLCO Stock Forecast

Bausch + Lomb (BLCO) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $22.43, with a high of $25.00 and a low of $19.00. This represents a 26.37% increase from the last price of $17.75.

$10 $13 $16 $19 $22 $25 High: $25 Avg: $22.43 Low: $19 Last Closed Price: $17.75

BLCO Stock Rating

Bausch + Lomb stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

BLCO Price Target Upside V Benchmarks

TypeNameUpside
StockBausch + Lomb26.37%
SectorHealthcare Stocks 25.00%
IndustryMedical Instruments & Supplies Stocks22.83%

Price Target Trends

1M3M12M
# Anlaysts-19
Avg Price Target-$19.00$21.67
Last Closing Price$17.75$17.75$17.75
Upside/Downside-7.04%22.08%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25339-116
Jan, 25339-116
Dec, 24449-118
Nov, 24457--16
Oct, 24458--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Patrick WoodMorgan Stanley$19.00$19.28-1.45%7.04%
Oct 31, 2024Yi ChenH.C. Wainwright$23.00$20.4412.52%29.58%
Oct 22, 2024Doug MiehmRBC Capital$23.00$20.6811.22%29.58%
Oct 15, 2024Larry BiegelsenWells Fargo$23.00$20.8710.21%29.58%
Oct 15, 2024Vijay KumarEvercore ISI$25.00$20.8719.79%40.85%
Sep 23, 2024Tom StephanStifel Nicolaus$19.00$19.85-4.28%7.04%
Sep 19, 2024Zachary WeinerJefferies$25.00$20.0624.63%40.85%
Jul 22, 2024Doug MiehmRBC Capital$20.00$16.9817.79%12.68%
May 06, 2024Patrick WoodMorgan Stanley$18.00$13.6032.35%1.41%
May 08, 2023Yi ChenH.C. Wainwright$19.00$18.164.63%7.04%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 12, 2024JefferiesBuyBuyhold
Oct 31, 2024CitigroupBuyBuyhold
Oct 31, 2024H.C. WainwrightBuyBuyhold
Oct 22, 2024RBC CapitalOutperformOutperformhold
Oct 15, 2024Wells FargoOverweightOverweighthold
Oct 15, 2024Evercore ISIPositiveOutperformupgrade
Oct 01, 2024Evercore ISIPositivePositivehold
Sep 23, 2024H.C. WainwrightBuyBuyhold
Sep 19, 2024JefferiesBuyBuyhold
Jul 22, 2024RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.04$-0.74-----
Avg Forecast$1.07$0.67$0.58$0.78$1.03$1.23$1.43
High Forecast$1.04$0.59$0.57$0.64$0.90$1.20$1.39
Low Forecast$1.09$0.72$0.59$0.93$1.17$1.28$1.48
Surprise %-96.26%-210.45%-----

Revenue Forecast

$4B $4B $5B $5B $6B $6B Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.77B$4.15B-----
Avg Forecast$3.74B$4.08B$4.77B$5.03B$5.33B$5.53B$5.75B
High Forecast$3.67B$3.99B$4.75B$4.92B$5.32B$5.52B$5.63B
Low Forecast$3.80B$4.09B$4.79B$5.15B$5.33B$5.54B$5.90B
Surprise %0.75%1.67%-----

Net Income Forecast

$-300M $-130M $40M $210M $380M $550M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.00M$-260.00M-----
Avg Forecast$373.56M$228.32M$204.15M$275.08M$362.20M$433.92M$501.22M
High Forecast$364.79M$205.31M$200.75M$224.91M$315.46M$420.71M$487.80M
Low Forecast$381.40M$251.33M$207.56M$325.26M$408.93M$447.13M$518.42M
Surprise %-95.98%-213.88%-----

BLCO Forecast FAQ

Is Bausch + Lomb stock a buy?

Bausch + Lomb stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Bausch + Lomb is a favorable investment for most analysts.

What is Bausch + Lomb's price target?

Bausch + Lomb's price target, set by 9 Wall Street analysts, averages $22.43 over the next 12 months. The price target range spans from $19 at the low end to $25 at the high end, suggesting a potential 26.37% change from the previous closing price of $17.75.

How does Bausch + Lomb stock forecast compare to its benchmarks?

Bausch + Lomb's stock forecast shows a 26.37% upside, outperforming the average forecast for the healthcare stocks sector (25.00%) and outperforming the medical instruments & supplies stocks industry (22.83%).

What is the breakdown of analyst ratings for Bausch + Lomb over the past three months?

  • February 2025: 18.75% Strong Buy, 18.75% Buy, 56.25% Hold, 0% Sell, 6.25% Strong Sell.
  • January 2025: 18.75% Strong Buy, 18.75% Buy, 56.25% Hold, 0% Sell, 6.25% Strong Sell.
  • December 2024: 22.22% Strong Buy, 22.22% Buy, 50.00% Hold, 0% Sell, 5.56% Strong Sell.

What is Bausch + Lomb’s EPS forecast?

Bausch + Lomb's average annual EPS forecast for its fiscal year ending in December is $0.58 for 2024, a -178.38% decrease from the reported $-0.74 in 2023. The prediction for 2025 is $0.78, $1.03 for 2026, $1.23 for 2027, and $1.43 for 2028.

What is Bausch + Lomb’s revenue forecast?

Bausch + Lomb's average annual revenue forecast for its fiscal year ending in December is $4.77B for 2024, a 15.02% increase from the reported $4.15B in 2023. The forecast for 2025 is $5.03B, $5.33B for 2026, $5.53B for 2027, and $5.75B for 2028.

What is Bausch + Lomb’s net income forecast?

For its fiscal year ending in December, Bausch + Lomb's average annual net income forecast is $204.15M for 2024, reflecting a -178.52% decrease from the reported $-260M in 2023. The projection for 2025 is $275.08M, $362.2M for 2026, $433.92M for 2027, and $501.22M for 2028.